ERLIN1 Gene SPG62 NGS Genetic DNA Test
Comprehensive Genetic Testing for Hereditary Spastic Paraplegia
The ERLIN1 Gene SPG62 NGS Genetic DNA Test represents a breakthrough in neurological genetic diagnostics, specifically designed to identify mutations associated with hereditary spastic paraplegia type 62 (SPG62). This advanced next-generation sequencing test provides crucial insights for individuals and families affected by progressive neurological conditions, enabling accurate diagnosis and informed medical decision-making.
What Does the ERLIN1 Gene SPG62 Test Measure?
This sophisticated genetic test utilizes cutting-edge NGS technology to analyze the ERLIN1 gene for specific mutations linked to SPG62, a form of hereditary spastic paraplegia. The test examines:
- Complete sequencing of the ERLIN1 gene coding regions
- Detection of point mutations, insertions, and deletions
- Identification of pathogenic variants affecting protein function
- Assessment of genetic markers associated with neurological degeneration
Who Should Consider ERLIN1 Gene Testing?
This test is particularly recommended for individuals experiencing:
- Progressive leg stiffness and muscle weakness
- Difficulty walking or changes in gait pattern
- Family history of hereditary spastic paraplegia
- Unexplained neurological symptoms in childhood or adulthood
- Muscle spasms and increased reflexes in lower limbs
- Early-onset mobility challenges without clear cause
Key Benefits of ERLIN1 Genetic Testing
- Accurate Diagnosis: Provides definitive identification of SPG62 genetic causes
- Family Planning: Enables informed reproductive decisions for at-risk families
- Early Intervention: Facilitates timely management strategies and treatments
- Personalized Care: Guides targeted therapeutic approaches and rehabilitation
- Genetic Counseling: Supports comprehensive family risk assessment
- Research Contribution: Advances understanding of neurological genetic disorders
Understanding Your Test Results
Your genetic test results will be carefully interpreted by our expert genetic counselors and neurologists:
- Positive Result: Indicates the presence of ERLIN1 gene mutation associated with SPG62
- Negative Result: Suggests no detected mutation in the ERLIN1 gene
- Variant of Uncertain Significance: Requires additional family studies and clinical correlation
- Carrier Status: Important information for family members and future generations
All results include comprehensive genetic counseling to ensure complete understanding and appropriate next steps for medical management.
Test Details and Pricing
| Test Component | Details |
|---|---|
| Test Name | ERLIN1 Gene SPG62 NGS Genetic DNA Test |
| Discount Price | $500 USD |
| Regular Price | $700 USD |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type | Blood, Extracted DNA, or One Drop Blood on FTA Card |
| Specialty | Neurology & Genetics |
| Testing Method | Next-Generation Sequencing (NGS) |
Pre-Test Requirements
Before scheduling your ERLIN1 Gene SPG62 test, we recommend:
- Comprehensive clinical history documentation
- Genetic counseling session to create detailed family pedigree
- Neurological evaluation and assessment
- Discussion of testing implications and potential outcomes
Nationwide Testing Availability
We provide comprehensive genetic testing services across the United States with convenient locations in all major cities including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network of certified genetic counselors and neurological specialists ensures you receive expert care regardless of your location.
Take Control of Your Neurological Health Today
Don’t let uncertainty about hereditary spastic paraplegia affect your quality of life. The ERLIN1 Gene SPG62 NGS Genetic DNA Test provides the clarity needed for proper diagnosis and management. Our team of genetic specialists and neurologists is ready to guide you through every step of the testing process.
Call +1(267) 388-9828 now to schedule your genetic counseling session and book your ERLIN1 Gene SPG62 test. Take the first step toward understanding your genetic health and securing your neurological future.
